Hormone Therapy for Prostate Cancer

Hormone therapy for prostate cancer aims to slow the growth of the cancer, mainly by reducing the effects of testosterone and other androgens. This approach is also known as ADT; however, it is not the sole treatment for every prostate cancer, and its purpose varies according to the stage of disease. ^[1][2][3]

What does hormone therapy mean in prostate cancer?

A large proportion of prostate cancer cells—especially in earlier disease and in some intermediate settings—depend on androgens, or male hormones, to grow. Hormone therapy, also called androgen deprivation therapy (ADT), aims either to reduce production of these hormones or to block their effect on cancer cells. The goal is to shrink the cancer, slow its growth, or enhance the effect of other treatments. ^[1][2][3]

The key point is that hormone therapy does not completely eliminate prostate cancer in every situation. In some patients, it is used together with radiotherapy; in others, it is a core component of treatment for metastatic disease; and in others again, it is used for recurrent disease. The aim is to control the tumour, reduce symptoms, and contribute to survival in the right patient. ^[1][2][4]

When is it used?

Hormone therapy may accompany radiotherapy in locally advanced disease, serve as a main treatment approach in metastatic disease, and re-enter the picture in some cases of recurrence. It is not started automatically in every early-stage, low-risk prostate cancer. The decision is based on tumour stage, PSA level, Gleason score/grade group, imaging findings, and overall health. ^[1][2][3]

In current practice, some metastatic cases may be treated not with classical ADT alone but with additional hormonal agents and sometimes chemotherapy. For that reason, the term “hormone therapy” describes a family of treatments rather than a single drug. Which combination is appropriate depends on the patient’s risk status and the extent of disease. ^[2][3][4]

What types of hormone therapy are there?

The most common approach uses medications that suppress testosterone production by the testes. In addition, drugs that block the androgen receptor or reduce androgen synthesis at different steps may be used. Less commonly, surgical orchiectomy is also an option. Whatever the specific method, the aim is to prevent the cancer cell from using hormonal signalling. ^[1][2][3]

In some patients, continuous treatment is discussed; in others, intermittent strategies may be considered. Even so, this is not a standard prescription applied the same way to everyone. Treatment planning is shaped by PSA response, symptoms, the presence of metastases, cardiovascular disease, and tolerance of side effects. It is not appropriate to assume that a drug taken by another patient would necessarily be suitable for you as well. ^[1][2][4]

How does hormone therapy work?

When androgen levels fall or their effect is blocked at the receptor level, growth of hormone-sensitive prostate cancer cells may slow. This may appear as a fall in PSA values, a decrease in tumour burden, or improvement in symptoms. In some patients, especially those with bone metastases, the contribution to pain control may be clinically important. ^[1][2][3]

Over time, however, some tumours may become less sensitive to hormonal treatment. This does not mean the treatment was “wrong”; rather, it reflects the fact that cancer biology can change. At that stage, additional imaging, a change in treatment, or other systemic therapies may become necessary. This is one reason why regular follow-up is so important. ^[1][2][3]

What are the side effects?

Although hormone therapy for prostate cancer can be effective, it has side effects. Hot flushes, reduced sexual desire, erectile dysfunction, loss of muscle mass, increased body fat, fatigue, and mood changes are common. Over longer periods, reduced bone density, metabolic changes, and cardiovascular risks may also become important. ^[1][2][3]

Monitoring these side effects is an integral part of treatment. Exercise, protecting bone health, nutrition, weight control, and additional medications when needed all matter during this process. Follow-up should be planned particularly carefully in people with diabetes, hypertension, or heart disease. Discussing these topics before treatment starts may reduce later problems. ^[1][2][4]

Is hormone therapy sufficient on its own?

In some patients, yes; in others, no. For example, in metastatic disease hormone therapy is often a core treatment, but in current practice additional therapies may also be appropriate in selected patients. Its combination with radiotherapy is also common in locally advanced disease. For that reason, the answer to the question “is it enough on its own?” depends on stage and risk group. ^[1][2][3]

As data have increasingly shown survival benefits with combination treatments in recent years, a single-agent approach is no longer considered sufficient for every patient. Even so, this does not mean that everyone will receive intensive treatment. Age, frailty, associated illnesses, and personal goals all influence treatment intensity. ^[2][3][4]

What should be monitored during follow-up?

In patients receiving hormone therapy, PSA levels, symptoms, imaging findings, and side effects are monitored regularly. Testosterone levels, bone health, body weight, and metabolic markers may also become important. New bone pain, weight loss, changes in urinary symptoms, or marked fatigue should always be mentioned during follow-up visits. ^[1][2][3]

Some people may use herbal supplements or testosterone-containing products assuming that they are harmless, but these can affect the treatment plan. For that reason, all supplements, including over-the-counter products, should be reported to the healthcare team. Living safely with treatment is as much a part of clinical management as the treatment goal itself. ^[1][2][4]

When should you contact a doctor?

Severe bone pain, sudden leg weakness, inability to urinate, marked shortness of breath, chest pain, or side effects that seriously impair daily life all require prompt medical evaluation. Depressive symptoms, falls, recurrent fractures, or rapid changes in weight should also be taken seriously during follow-up. ^[1][2][3]

Hormone therapy is a very important treatment tool for prostate cancer in the right patient. Even so, the choice of drug, duration, and whether it is used alone or in combination all require individualized assessment. The treatment plan should be made together with the uro-oncology and medical oncology team. ^[1][2][4]